Skip to main content
OpenTrials

Clinical trial condition

Oligometastatic Prostate Carcinoma

Explore clinical trials studying Oligometastatic Prostate Carcinoma. Study availability and eligibility vary by location and protocol.

10 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Oligometastatic Prostate Carcinoma trial results

Recruiting

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

NCT06205316

Conditions
Biochemically Recurrent Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +14 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
  • Mayo Clinic Health System - Mankato Mankato, Minnesota, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Not Yet Recruiting

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

NCT05707468

Conditions
Oligometastatic Prostate Carcinoma
Locations
  • the First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • First Affiliated Hospital and Medical College of Soochow University Suzhou, Jiangsu, China
  • Jiangnan University Medical Center Wuxi, Jiangsu, China
  • The First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China
View Trial Details
Active, Not Recruiting

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

NCT05053152

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Marin General Hospital Greenbrae, California, United States
View all 245 locations
View Trial Details
Active, Not Recruiting

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

NCT06229366

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +13 more
Locations
  • Juravinski Hamilton, Canada
  • Jewish General Hospital Montreal, Canada
  • McGill University Montreal, Canada
  • Centre Hospitalier Universite de QUEBEC Québec, Canada
View Trial Details

Related conditions